Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Recombinant Protein / Other Proteins

Recombinant Human KYNU Protein, N-His

Catalog #:   YHH35701 Specific References (50) DATASHEET
Applications: ELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress
Expression system: E. coli
Accession: Q16719
Protein length: Met1-Ala301
Overview

Catalog No.

YHH35701

Expression system

E. coli

Species

Homo sapiens (Human)

Protein length

Met1-Ala301

Predicted molecular weight

36.16 kDa

Nature

Recombinant

Endotoxin level

Please contact with the lab for this information.

Purity

>90% as determined by SDS-PAGE.

Accession

Q16719

Applications

ELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress

Form

Lyophilized

Storage buffer

Lyophilized from a solution in PBS pH 7.4, 0.02% NLS, 1mM EDTA, 4% Trehalose, 1% Mannitol.

Reconstitution

Reconstitute in sterile water for a stock solution. A copy of datasheet will be provided with the products, please refer to it for details.

Shipping

In general, proteins are provided as lyophilized powder/frozen liquid. They are shipped out with dry ice/blue ice unless customers require otherwise.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.

Alternative Names

KYNU, Kynureninase, L-kynurenine hydrolase

Data Image
  • SDS-PAGE
    SDS PAGE for recombinant Human KYNU protein
References

Exploring causal plasma protein level ratios and potential drug targets for depression: A proteomics Mendelian randomization study., PMID:40499826

GPX4 knockdown suppresses M2 macrophage polarization in gastric cancer by modulating kynurenine metabolism., PMID:40365295

Identification of the shared gene signatures and biological mechanism in type 2 diabetes mellitus and hepatocellular carcinoma., PMID:40303585

Breast cancer metastasis progression is associated with elevated activity of kynurenine monooxygenase and kynureninase., PMID:39558063

Elucidating common biomarkers and pathways of osteoporosis and aortic valve calcification: insights into new therapeutic targets., PMID:39537712

Gene expression of kynurenine pathway enzymes in depression and following electroconvulsive therapy., PMID:39417574

Characterization of Circulating Protein Profiles in Individuals with Prader-Willi Syndrome and Individuals with Non-Syndromic Obesity., PMID:39407757

Rhodoquinone-dependent electron transport chain is essential for Caenorhabditis elegans survival in hydrogen sulfide environments., PMID:39178951

Neurological-related proteomic profiling in plasma of children with metabolic healthy and unhealthy overweight/obesity., PMID:39075931

Evaluation of Kynu, Defb2, Camp, and Penk Expression Levels as Psoriasis Marker in the Imiquimod-Induced Psoriasis Model., PMID:39045230

Dissecting gastric cancer heterogeneity and exploring therapeutic strategies using bulk and single-cell transcriptomic analysis and experimental validation of tumor microenvironment and metabolic interplay., PMID:38962317

Developing a novel immune infiltration-associated mitophagy prediction model for amyotrophic lateral sclerosis using bioinformatics strategies., PMID:38601155

KYNU Expression Promotes Cisplatin Resistance in Esophageal Cancer., PMID:38577600

Identification of potential drug targets for allergic diseases from a genetic perspective: A mendelian randomization study., PMID:38573314

A metabolic signature for NADSYN1-dependent congenital NAD deficiency disorder., PMID:38357931

Identification of potential crucial genes shared in psoriasis and ulcerative colitis by machine learning and integrated bioinformatics., PMID:38303405

On the benefits of the tryptophan metabolite 3-hydroxyanthranilic acid in Caenorhabditis elegans and mouse aging., PMID:38097593

Particulate matter-induced metabolic recoding of epigenetics in macrophages drives pathogenesis of chronic obstructive pulmonary disease., PMID:37988864

Kynureninase knockdown inhibits cisplatin resistance in vivo and in vitro and impacts the prognosis of cervical adenocarcinoma., PMID:37742026

Gbp3 is associated with the progression of lupus nephritis by regulating cell proliferation, inflammation and pyroptosis., PMID:37621179

Bioinformatic Analysis of the Potential Common Pathogenic Mechanisms for Psoriasis and Metabolic Syndrome., PMID:37222907

Identification of novel interacts partners of ADAR1 enzyme mediating the oncogenic process in aggressive breast cancer., PMID:37221310

Glutathione peroxidase 2 knockdown suppresses gastric cancer progression and metastasis via regulation of kynurenine metabolism., PMID:37138031

Plasma levels of neurology-related proteins are associated with cognitive performance in an older population with overweight/obesity and metabolic syndrome., PMID:36964401

Kynureninase Upregulation Is a Prominent Feature of NFR2-Activated Cancers and Is Associated with Tumor Immunosuppression and Poor Prognosis., PMID:36765792

Organ Protection by Caloric Restriction Depends on Activation of the De Novo NAD+ Synthesis Pathway., PMID:36758124

Targeted proteomic scan identifies alteration of serum proteins among workers occupationally exposed to low levels of trichloroethylene., PMID:36346153

Tryptophan metabolism and disposition in cancer biology and immunotherapy., PMID:36286592

IDO promotes the proliferation and invasion of prostate cancer cells through KYNU., PMID:36264416

Identification and characterization of the kynurenine pathway in the pond snail Lymnaea stagnalis., PMID:36114337

Mouse Model of Weak Depression Exhibiting Suppressed cAMP Signaling in the Amygdala, Lower Lipid Catabolism in Liver, and Correlated Gut Microbiota., PMID:35928791

Differential Gene Expression and Methylation Analysis of Melanoma in TCGA Database to Further Study the Expression Pattern of KYNU in Melanoma., PMID:35893303

HIV-1 Tat and cocaine impact astrocytic energy reservoirs and epigenetic regulation by influencing the LINC01133-hsa-miR-4726-5p-NDUFA9 axis., PMID:35892093

Human 5-lipoxygenase regulates transcription by association to euchromatin., PMID:35878796

Further characterization of tryptophan metabolism and its dysregulation in fibroids., PMID:35715314

Mutational Activation of the NRF2 Pathway Upregulates Kynureninase Resulting in Tumor Immunosuppression and Poor Outcome in Lung Adenocarcinoma., PMID:35626147

Further description of two patients with biallelic variants in NADSYN1 in association with cardiac and vertebral anomalies., PMID:35491967

Re-sequencing of candidate genes FOXF1, HSPA6, HAAO, and KYNU in 522 individuals with VATER/VACTERL, VACTER/VACTERL-like association, and isolated anorectal malformation., PMID:35362267

Yixin Ningshen Tablet Alleviates Comorbidity of Myocardial Infarction and Depression by Enhancing Myocardial Energy Metabolism and Increasing Availability of Monoamine Neurotransmitter., PMID:35319073

The TZM-bl Reporter Cell Line Expresses Kynureninase That Can Neutralize 2F5-like Antibodies in the HIV-1 Neutralization Assay., PMID:35054825

The Role and Mechanism of SIRT6 in Regulating Phenotype Transformation of Vascular Smooth Muscle Cells in Abdominal Aortic Aneurysm., PMID:35035519

Alterations in Kynurenine and NAD+ Salvage Pathways during the Successful Treatment of Inflammatory Bowel Disease Suggest HCAR3 and NNMT as Potential Drug Targets., PMID:34948292

A metabolism-relevant signature as a predictor for prognosis and therapeutic response in pancreatic cancer., PMID:34632851

DNA Damage, n-3 Long-Chain PUFA Levels and Proteomic Profile in Brazilian Children and Adolescents., PMID:34444642

Cancer-associated fibroblasts educate normal fibroblasts to facilitate cancer cell spreading and T-cell suppression., PMID:34379869

Genetic Analysis of Tryptophan Metabolism Genes in Sporadic Amyotrophic Lateral Sclerosis., PMID:34194442

Cross-Tissue Transcriptomic Analysis Leveraging Machine Learning Approaches Identifies New Biomarkers for Rheumatoid Arthritis., PMID:34177888

TDO2 knockdown inhibits colorectal cancer progression via TDO2-KYNU-AhR pathway., PMID:34051337

Changes in gene expression of adipose tissue CD14+ cells in patients with Type 2 diabetes mellitus and their relationship with environmental factors., PMID:33678630

KYNU, a novel potential target that underpins CD44-promoted breast tumour cell invasion., PMID:33486887

Datasheet
$ 313
Product specifications
100 μg 313 1 mg 1629

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

Recombinant Human KYNU Protein, N-His [YHH35701]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2025 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only